ArticleDigital health
An integrative framework for estimating personal healthy life expectancy from personal health records.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Healthy life expectancy is conventionally calculated at the population level, with no standardized approach for estimating it for individuals. Despite the increasing availability of personal health records (PHRs), comprehensive personalized health indicators remain scarce. This study aimed to develop a framework for estimating personal healthy life expectancy using PHR data. Methods: We used the combined dataset of the Comprehensive Survey of Living Conditions and the National Health and Nutrition Survey conducted for randomly sampled general population in Japan, 2019. From the merged dataset, 5552 respondents were included for the analysis. Machine learning models were constructed to predict activity limitation-a key determinant of healthy life expectancy-using age, sex, disease history, blood test results, and lifelog variables (blood pressure, body mass index, waist circumference, daily step counts, and sleep patterns). Subsequently, an equation was derived for estimating personal healthy life expectancy through a mathematical algorithm. Results: The prediction model achieved an area under the receiver operating characteristic curve of 0.84. Personal healthy life expectancy was estimated using a derived equation in which an individual's probability of having no activity limitation, relative to their age group average, was scaled by the population-level healthy life expectancy. Conclusion: We developed a novel framework for estimating personal healthy life expectancy from PHR data, incorporating both lifelog data and blood biomarkers, by machine-learning and mathematical approach. The application of this individualized health metric may advance personalized medicine, preventive health strategies, and tailored health guidance, while serving as a behavioral nudge to promote healthier lifestyles. It should be noted, however, that because the framework is derived from cross-sectional data, it does not estimate when future activity limitations may occur.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.